HT61: New drug antibacterial MRSA

St. School of Medicine scientists George, London, England studied a MRSA antimicrobial drug called HT61, which reduced the treatment time for patients with antibiotics by half the time.

New drug HT61 antibacterial MRSA is similar to a cream used to prevent the existence of MRSA bacteria in the antibiotic resistant nose.

New drug HT61 antibodies to MRSA reduce the treatment time for patients with antibiotics by half.(Photo: BBC)

Like all bacteria, MRSA bacteria are divided into two types: the rapidly dividing bacteria will be destroyed by the existing antibiotics and residual form lurking in the body. so reinfection - the cause of drug resistance.

In order to treat the disease with antibiotics effectively, many hospitals have had to perform MRSA test before surgery.

The drug HT61 has been successfully tested in animals against surviving MRSA bacteria. In early 2007, the new antibiotic will be tested by scientists to treat 60 patients and drugs will be widely circulated within the next 5 years.

GS. Anthony Coates, lead researcher said: 'New MRSA antimicrobial drugs HT61 against MRSA bacteria are very effective during treatment with current antibiotics.

Patients treated with antibiotics with antimicrobial drugs HT61 will reduce treatment time to 1-2 days instead of 5-7 days of treatment as before ".

The success of this study has opened up the prospect of treatment with existing antibiotics more effectively and the study of other treatment drugs with residual bacteria.

mystical gem